Selected research
Industry Research
Veterinary Renal Disease Industry Research Report 2026
Market perspective
The global Veterinary Renal Disease market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Veterinary Renal Disease market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Veterinary Renal Disease market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Veterinary Renal Disease market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Veterinary Renal Disease include Zoetis, Nestle Purina PetCare, Mars, Hill's Pet Nutrition, The J.M. Smucker Company, General Mills, Merck, Elanco Animal Health and Phibro Animal Health Corporation and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Veterinary Renal Disease market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Veterinary Renal Disease.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Renal Disease Market by Company
Zoetis
Nestle Purina PetCare
Mars
Hill's Pet Nutrition
The J.M. Smucker Company
General Mills
Merck
Elanco Animal Health
Phibro Animal Health Corporation
Ceva Sante Animale
Veterinary Renal Disease Segment by Type
Diagnosis
Treatment
Others
Veterinary Renal Disease Segment by Application
Veterinary Hospitals & Clinics
Pet Speciality Stores
Others
Veterinary Renal Disease Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Renal Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Renal Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Renal Disease.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Veterinary Renal Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Diagnosis
- Treatment
- Others
Applications
- Veterinary Hospitals & Clinics
- Pet Speciality Stores
- Others
Companies covered
- Zoetis
- Nestle Purina PetCare
- Mars
- Hill's Pet Nutrition
- The J.M. Smucker Company
- General Mills
- Merck
- Elanco Animal Health
- Phibro Animal Health Corporation
- Ceva Sante Animale
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Veterinary Renal Disease by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Diagnosis
- 2.2.3 Treatment
- 2.2.4 Others
- 2.3 Veterinary Renal Disease by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Veterinary Hospitals & Clinics
- 2.3.3 Pet Speciality Stores
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Veterinary Renal Disease Breakdown Data by Type
- 3.1 Global Veterinary Renal Disease Historic Market Size by Type (2021-2026)
- 3.2 Global Veterinary Renal Disease Forecasted Market Size by Type (2027-2032)
4 Veterinary Renal Disease Breakdown Data by Application
- 4.1 Global Veterinary Renal Disease Historic Market Size by Application (2021-2026)
- 4.2 Global Veterinary Renal Disease Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Veterinary Renal Disease Market Perspective (2021-2032)
- 5.2 Global Veterinary Renal Disease Growth Trends by Region
- 5.2.1 Global Veterinary Renal Disease Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Veterinary Renal Disease Historic Market Size by Region (2021-2026)
- 5.2.3 Veterinary Renal Disease Forecasted Market Size by Region (2027-2032)
- 5.3 Veterinary Renal Disease Market Dynamics
- 5.3.1 Veterinary Renal Disease Industry Trends
- 5.3.2 Veterinary Renal Disease Market Drivers
- 5.3.3 Veterinary Renal Disease Market Challenges
- 5.3.4 Veterinary Renal Disease Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Veterinary Renal Disease Players by Revenue
- 6.1.1 Global Top Veterinary Renal Disease Players by Revenue (2021-2026)
- 6.1.2 Global Veterinary Renal Disease Revenue Market Share by Players (2021-2026)
- 6.2 Global Veterinary Renal Disease Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Veterinary Renal Disease Head Office and Area Served
- 6.4 Global Veterinary Renal Disease Players, Product Type & Application
- 6.5 Global Veterinary Renal Disease Manufacturers Established Date
- 6.6 Global Veterinary Renal Disease Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Veterinary Renal Disease Market Size (2021-2032)
- 7.2 North America Veterinary Renal Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Veterinary Renal Disease Market Size by Country (2021-2026)
- 7.4 North America Veterinary Renal Disease Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Veterinary Renal Disease Market Size (2021-2032)
- 8.2 Europe Veterinary Renal Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Veterinary Renal Disease Market Size by Country (2021-2026)
- 8.4 Europe Veterinary Renal Disease Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Veterinary Renal Disease Market Size (2021-2032)
- 9.2 Asia-Pacific Veterinary Renal Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Veterinary Renal Disease Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Veterinary Renal Disease Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Veterinary Renal Disease Market Size (2021-2032)
- 10.2 South America Veterinary Renal Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Veterinary Renal Disease Market Size by Country (2021-2026)
- 10.4 South America Veterinary Renal Disease Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Veterinary Renal Disease Market Size (2021-2032)
- 11.2 Middle East & Africa Veterinary Renal Disease Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Veterinary Renal Disease Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Veterinary Renal Disease Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Zoetis
- 12.1.1 Zoetis Company Information
- 12.1.2 Zoetis Business Overview
- 12.1.3 Zoetis Revenue in Veterinary Renal Disease Business (2021-2026)
- 12.1.4 Zoetis Veterinary Renal Disease Product Portfolio
- 12.1.5 Zoetis Recent Developments
- 12.2 Nestle Purina PetCare
- 12.2.1 Nestle Purina PetCare Company Information
- 12.2.2 Nestle Purina PetCare Business Overview
- 12.2.3 Nestle Purina PetCare Revenue in Veterinary Renal Disease Business (2021-2026)
- 12.2.4 Nestle Purina PetCare Veterinary Renal Disease Product Portfolio
- 12.2.5 Nestle Purina PetCare Recent Developments
- 12.3 Mars
- 12.3.1 Mars Company Information
- 12.3.2 Mars Business Overview
- 12.3.3 Mars Revenue in Veterinary Renal Disease Business (2021-2026)
- 12.3.4 Mars Veterinary Renal Disease Product Portfolio
- 12.3.5 Mars Recent Developments
- 12.4 Hill's Pet Nutrition
- 12.4.1 Hill's Pet Nutrition Company Information
- 12.4.2 Hill's Pet Nutrition Business Overview
- 12.4.3 Hill's Pet Nutrition Revenue in Veterinary Renal Disease Business (2021-2026)
- 12.4.4 Hill's Pet Nutrition Veterinary Renal Disease Product Portfolio
- 12.4.5 Hill's Pet Nutrition Recent Developments
- 12.5 The J.M. Smucker Company
- 12.5.1 The J.M. Smucker Company Company Information
- 12.5.2 The J.M. Smucker Company Business Overview
- 12.5.3 The J.M. Smucker Company Revenue in Veterinary Renal Disease Business (2021-2026)
- 12.5.4 The J.M. Smucker Company Veterinary Renal Disease Product Portfolio
- 12.5.5 The J.M. Smucker Company Recent Developments
- 12.6 General Mills
- 12.6.1 General Mills Company Information
- 12.6.2 General Mills Business Overview
- 12.6.3 General Mills Revenue in Veterinary Renal Disease Business (2021-2026)
- 12.6.4 General Mills Veterinary Renal Disease Product Portfolio
- 12.6.5 General Mills Recent Developments
- 12.7 Merck
- 12.7.1 Merck Company Information
- 12.7.2 Merck Business Overview
- 12.7.3 Merck Revenue in Veterinary Renal Disease Business (2021-2026)
- 12.7.4 Merck Veterinary Renal Disease Product Portfolio
- 12.7.5 Merck Recent Developments
- 12.8 Elanco Animal Health
- 12.8.1 Elanco Animal Health Company Information
- 12.8.2 Elanco Animal Health Business Overview
- 12.8.3 Elanco Animal Health Revenue in Veterinary Renal Disease Business (2021-2026)
- 12.8.4 Elanco Animal Health Veterinary Renal Disease Product Portfolio
- 12.8.5 Elanco Animal Health Recent Developments
- 12.9 Phibro Animal Health Corporation
- 12.9.1 Phibro Animal Health Corporation Company Information
- 12.9.2 Phibro Animal Health Corporation Business Overview
- 12.9.3 Phibro Animal Health Corporation Revenue in Veterinary Renal Disease Business (2021-2026)
- 12.9.4 Phibro Animal Health Corporation Veterinary Renal Disease Product Portfolio
- 12.9.5 Phibro Animal Health Corporation Recent Developments
- 12.10 Ceva Sante Animale
- 12.10.1 Ceva Sante Animale Company Information
- 12.10.2 Ceva Sante Animale Business Overview
- 12.10.3 Ceva Sante Animale Revenue in Veterinary Renal Disease Business (2021-2026)
- 12.10.4 Ceva Sante Animale Veterinary Renal Disease Product Portfolio
- 12.10.5 Ceva Sante Animale Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst